Development of cancer immune evaluation tool
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0002469
- Lead Sponsor
- Seoul Songdo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
1. Patients with colorectal cancer confirmed by radiologic imaging and histological test
2. those who over 20 years old
3. patients who understand study and signed an informed consent
Exclusion Criteria
1. patients experienced with incidence or surgery of other cancers
2. Recurred patients with colorectal cancer
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method expression level of primary receptors on suppressive immune cells such as regulatory T cells and Myeloid-derived suppressor cells
- Secondary Outcome Measures
Name Time Method Cytokines, chemokines, cancer growth and angiogenesis factors